Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA: 600380)

Joincare Pharmaceutical Group Industry Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15,259	15,692	14,808	11,729	12,289	11,189
Short-Term Investments	400.11	406.38	54.05	-	-	-
Trading Asset Securities	67.94	82.9	109.02	184.64	28.33	18.12
Cash & Short-Term Investments	15,727	16,181	14,972	11,914	12,317	11,207
Cash Growth	6.95%	8.08%	25.66%	-3.28%	9.90%	-2.44%
Accounts Receivable	4,850	4,634	5,064	4,831	3,790	3,344
Other Receivables	76.19	46.01	52.54	88.05	197.17	126.79
Receivables	4,926	4,680	5,116	4,919	3,988	3,471
Inventory	2,596	2,656	2,562	2,079	1,832	1,528
Other Current Assets	353.31	357.51	527.81	453.22	268.02	378
Total Current Assets	23,603	23,875	23,178	19,365	18,405	16,585
Property, Plant & Equipment	6,257	6,193	6,118	5,629	5,047	4,634
Long-Term Investments	3,460	3,206	3,426	2,880	2,205	2,016
Goodwill	636.34	636.34	614.47	614.47	614.47	614.47
Other Intangible Assets	759.15	683.34	802.12	456.78	468.09	374.19
Long-Term Accounts Receivable	-	-	-	0.27	-	-
Long-Term Deferred Tax Assets	617.9	579.53	540.04	552.54	468.9	381.23
Long-Term Deferred Charges	440.34	483.49	428.28	786.99	399.12	440.65
Other Long-Term Assets	722.93	702.25	628.27	818.36	550.38	392.36
Total Assets	36,496	36,358	35,735	31,104	28,157	25,438
Accounts Payable	2,384	2,363	2,580	2,454	1,920	1,372
Accrued Expenses	3,902	3,947	4,178	3,749	3,258	2,776
Short-Term Debt	1,850	2,076	2,126	2,518	2,111	2,162
Current Portion of Long-Term Debt	1,572	696.48	43.66	70.28	-	518.7
Current Portion of Leases	20.89	22.09	19.42	21.3	8.54	-
Current Income Taxes Payable	142.06	248.97	124.04	145.11	197.93	166.8
Current Unearned Revenue	112.25	159.08	292.98	234.14	133.42	169.7
Other Current Liabilities	1,141	347.14	390.77	160.17	172.99	207.48
Total Current Liabilities	11,125	9,861	9,755	9,352	7,802	7,373
Long-Term Debt	1,554	3,122	3,231	826.78	360.32	-
Long-Term Leases	11.59	15.42	23.48	25.07	9.82	-
Long-Term Unearned Revenue	354.04	370.18	384.54	433.54	467.56	429.28
Long-Term Deferred Tax Liabilities	247.4	260.03	237.19	208.53	202.26	181.64
Other Long-Term Liabilities	90	90	84	78	78	70
Total Liabilities	13,382	13,719	13,715	10,924	8,920	8,054
Common Stock	1,874	1,866	1,929	1,908	1,953	1,938
Additional Paid-In Capital	1,470	1,352	2,222	2,153	2,531	2,404
Retained Earnings	10,739	10,301	9,192	7,864	6,747	5,897
Treasury Stock	-	-	-347.18	-222.64	-253.64	-
Comprensive Income & Other	228.81	237.07	126.72	117.88	118.57	116.95
Total Common Equity	14,312	13,756	13,122	11,820	11,096	10,356
Minority Interest	8,801	8,884	8,898	8,359	8,141	7,028
Shareholders' Equity	23,114	22,640	22,020	20,180	19,237	17,384
Total Liabilities & Equity	36,496	36,358	35,735	31,104	28,157	25,438
Total Debt	5,009	5,932	5,443	3,462	2,490	2,680
Net Cash (Debt)	10,718	10,249	9,528	8,452	9,828	8,527
Net Cash Growth	25.58%	7.56%	12.73%	-14.00%	15.25%	9.48%
Net Cash Per Share	5.69	5.37	5.02	4.36	5.02	4.39
Filing Date Shares Outstanding	1,874	1,866	1,928	1,890	1,933	1,938
Total Common Shares Outstanding	1,874	1,866	1,928	1,890	1,933	1,938
Working Capital	12,478	14,014	13,423	10,013	10,602	9,212
Book Value Per Share	7.64	7.37	6.81	6.25	5.74	5.34
Tangible Book Value	12,917	12,436	11,705	10,749	10,014	9,367
Tangible Book Value Per Share	6.89	6.67	6.07	5.69	5.18	4.83
Buildings	4,643	4,619	4,279	3,950	-	3,557
Machinery	7,239	7,108	6,524	5,928	8,985	4,681
Construction In Progress	739.49	531.06	811.3	743	648.48	564.99

Source: S&P Capital IQ. Standard template. Financial Sources.